COVID-19 Vaccine Information/Operation Warp Speed
Monoclonal Antibody more
Letter of Authorization – Eli Lilly Bebtelovimab Emergency Use Authorization
ASPR pauses allocation of bamlanivimab and etesevimab together, etesevimab alone, and REGEN-COV
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR EVUSHELD™
Sotrovimab Monoclonal Antibody for the Treatment of Mild to Moderate COVID-19 (outpatient)
Actemra® for the Treatment of COVID-19 (inpatient)
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR ACTEMRA® (tocilizumab)
CMS Payment Allowance for COVID-19 Vaccines and Monoclonal Antibodies
Public Health Emergency Information for Casirivimab/Imdevimab
Public Health Emergency Information for Bamlanivimab
Antivirals more
Fact Sheet for Healthcare Providers: Emergency Use Authorization for Paxlovid™ Medication Safety Issues with Newly Authorized PAXLOVID™ Upcoming Webinars/Hearings more
Past Webinars more
Alternate Site (Home Infusion/Specialty) Pharmacy Resources more
Clinical Resources more
MHA is pleased to provide MHA members with insights from IPD Analytics. They are continuing to monitor the impact of COVID-19 to the pharmaceutical industry with respect to clinical trials aimed at vaccine development and investigational and currently available treatments. IPD Analytics COVID Treatments 7.15.2021 IPD Analytics COVID Vaccines 7.15.2021 Center for Infectious Disease Research and Policy, University of Minnesota COVID-19 DEA Diversion Control Division Coronavirus Resources FDA Coronavirus Treatment Acceleration Program (CTAP) Infectious Disease Society of America Society of Critical Care Medicine Society of Infectious Disease Pharmacists COVID 19 Resource University of Nebraska Medical Center COVID-19 University of Washington COVID-19 Center, including sample policies and procedures Wolters Kluwer Up-To-Date Clinical Effectiveness COVID-19 Resources (Available to all) CMS/HHS more
Data and Projections more
Institute for Health Metric and Evaluation (HME) Coronavirus US Projections Drug Shortage Information more
General Trade Information more
Healthcare Information and Management Systems Society, Inc. (HIMSS) Health Industry Distributors Association COVID-19 Resource Center HIPAA more
Urgent Notices FBI Sees Rise in Fraud Schemes Related to the Coronavirus (COVID-19) Pandemic HHS Office for Civil Rights in Action Long Term Care Facilities more
AHCA/NCAL Coronavirus Resource Page COVID-19 Nursing Home Data (and Count Positivity Rates) FCC COVID-19 Telehealth Program (OMB Control Number 3060-1271) FCC Report and Order Establishing COVID-19 Telehealth Program (WC Docket No. 20-89) (Page 13: “Eligible Health Care Providers. Consistent with the 1996 Act and the CARES Act, we limit the program to nonprofit and public eligible health care providers that fall within the categories of health care providers…”) Long Term Care Pharmacy Resources more
MHA Response to COVID-19 more
Small Business more
Department of Labor Coronavirus Resources US Dept of Labor, Families First Coronavirus Response Act: FAQ State Resources more
Testing more
Updated CDC Guidance on Antigen Testing in Long Term Care Facilities; 1.7.2021 U.S. Congress more
Not finding what you need? Email MHAadvocate@mhainc.com and let us know!
Scammers are leveraging the COVID-19 pandemic to steal your money, your personal information, or both. The FBI advises you to be on the lookout for the following: Fake CDC Emails, Phishing Emails, Counterfeit Treatments or Equipment. Visit the FBI site for more information.
It has come to OCR’s attention that an individual posing as an OCR Investigator has contacted HIPAA covered entities in an attempt to obtain protected health information (PHI). The individual identifies themselves on the telephone as an OCR investigator but does not provide an OCR complaint transaction number or any other verifiable information relating to an OCR investigation. Visit the NIH site for more information.